BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32358194)

  • 1. Acoustofluidic sonoporation for gene delivery to human hematopoietic stem and progenitor cells.
    Belling JN; Heidenreich LK; Tian Z; Mendoza AM; Chiou TT; Gong Y; Chen NY; Young TD; Wattanatorn N; Park JH; Scarabelli L; Chiang N; Takahashi J; Young SG; Stieg AZ; De Oliveira S; Huang TJ; Weiss PS; Jonas SJ
    Proc Natl Acad Sci U S A; 2020 May; 117(20):10976-10982. PubMed ID: 32358194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable transgene expression in primitive human CD34+ hematopoietic stem/progenitor cells, using the Sleeping Beauty transposon system.
    Sumiyoshi T; Holt NG; Hollis RP; Ge S; Cannon PM; Crooks GM; Kohn DB
    Hum Gene Ther; 2009 Dec; 20(12):1607-26. PubMed ID: 19689196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sonoporation: Past, Present, and Future.
    Rich J; Tian Z; Huang TJ
    Adv Mater Technol; 2022 Jan; 7(1):. PubMed ID: 35399914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic Stem Cell Gene Therapy for Brain Metastases Using Myeloid Cell-Specific Gene Promoters.
    Andreou T; Rippaus N; Wronski K; Williams J; Taggart D; Cherqui S; Sunderland A; Kartika YD; Egnuni T; Brownlie RJ; Mathew RK; Holmen SL; Fife C; Droop A; Lorger M
    J Natl Cancer Inst; 2020 Jun; 112(6):617-627. PubMed ID: 31501884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-mediated gene delivery: kinetics of plasmid internalization and gene expression.
    Mehier-Humbert S; Bettinger T; Yan F; Guy RH
    J Control Release; 2005 May; 104(1):203-11. PubMed ID: 15866346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Acoustofluidic and Static Systems for Ultrasound-Mediated Molecular Delivery to T Lymphocytes.
    Centner CS; Moore JT; Baxter ME; Yaddanapudi K; Bates PJ; Kopechek JA
    Ultrasound Med Biol; 2023 Jan; 49(1):90-105. PubMed ID: 36241589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding and overcoming adverse consequences of genome editing on hematopoietic stem and progenitor cells.
    Lee BC; Lozano RJ; Dunbar CE
    Mol Ther; 2021 Nov; 29(11):3205-3218. PubMed ID: 34509667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted, safe, and efficient gene delivery to human hematopoietic stem and progenitor cells in vivo using the engineered AVID adenovirus vector platform.
    Yao J; Atasheva S; Wagner N; Di Paolo NC; Stewart PL; Shayakhmetov DM
    Mol Ther; 2024 Jan; 32(1):103-123. PubMed ID: 37919899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell engineering at a crossroads.
    Rivière I; Dunbar CE; Sadelain M
    Blood; 2012 Feb; 119(5):1107-16. PubMed ID: 22096239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosage-controlled intracellular delivery mediated by acoustofluidics for lab on a chip applications.
    Salari A; Appak-Baskoy S; Coe IR; Abousawan J; Antonescu CN; Tsai SSH; Kolios MC
    Lab Chip; 2021 May; 21(9):1788-1797. PubMed ID: 33734246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-Bicelle-Coated Microfluidics for Intracellular Delivery with Reduced Fouling.
    Belling JN; Heidenreich LK; Park JH; Kawakami LM; Takahashi J; Frost IM; Gong Y; Young TD; Jackman JA; Jonas SJ; Cho NJ; Weiss PS
    ACS Appl Mater Interfaces; 2020 Oct; 12(41):45744-45752. PubMed ID: 32940030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice.
    Fujii H; Sun Z; Li SH; Wu J; Fazel S; Weisel RD; Rakowski H; Lindner J; Li RK
    JACC Cardiovasc Imaging; 2009 Jul; 2(7):869-79. PubMed ID: 19608138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome editing in human hematopoietic stem and progenitor cells via CRISPR-Cas9-mediated homology-independent targeted integration.
    Bloomer H; Smith RH; Hakami W; Larochelle A
    Mol Ther; 2021 Apr; 29(4):1611-1624. PubMed ID: 33309880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microfluidic transfection of mRNA into human primary lymphocytes and hematopoietic stem and progenitor cells using ultra-fast physical deformations.
    Loo J; Sicher I; Goff A; Kim O; Clary N; Alexeev A; Sulchek T; Zamarayeva A; Han S; Calero-Garcia M
    Sci Rep; 2021 Nov; 11(1):21407. PubMed ID: 34725429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene transfer: how can the biological barriers be overcome?
    Escoffre JM; Teissié J; Rols MP
    J Membr Biol; 2010 Jul; 236(1):61-74. PubMed ID: 20623114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmid DNA size does affect nonviral gene delivery efficiency in stem cells.
    Ribeiro S; Mairhofer J; Madeira C; Diogo MM; Lobato da Silva C; Monteiro G; Grabherr R; Cabral JM
    Cell Reprogram; 2012 Apr; 14(2):130-7. PubMed ID: 22339198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence-based selection of gene-corrected hematopoietic stem and progenitor cells from acid sphingomyelinase-deficient mice: implications for Niemann-Pick disease gene therapy and the development of improved stem cell gene transfer procedures.
    Erlich S; Miranda SR; Visser JW; Dagan A; Gatt S; Schuchman EH
    Blood; 1999 Jan; 93(1):80-6. PubMed ID: 9864149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound‑targeted microbubbles combined with a peptide nucleic acid binding nuclear localization signal mediate transfection of exogenous genes by improving cytoplasmic and nuclear import.
    Jiang N; Chen Q; Cao S; Hu B; Wang YJ; Zhou Q; Guo RQ
    Mol Med Rep; 2017 Dec; 16(6):8819-8825. PubMed ID: 28990051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparameter evaluation of in vivo gene delivery using ultrasound-guided, microbubble-enhanced sonoporation.
    Shapiro G; Wong AW; Bez M; Yang F; Tam S; Even L; Sheyn D; Ben-David S; Tawackoli W; Pelled G; Ferrara KW; Gazit D
    J Control Release; 2016 Feb; 223():157-164. PubMed ID: 26682505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo gene transfer and correction for cell-based therapies.
    Naldini L
    Nat Rev Genet; 2011 May; 12(5):301-15. PubMed ID: 21445084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.